MedTrace Logo

Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study

NCT01353768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2016-11-23

No results posted yet for this study

Summary

GSK is conducting a global retrospective chart review of patients treated with zanamivir as part of the Compassionate Use Program (CUP), in an effort to collect as much information as possible on the use of this investigational drug. The retrospective chart review is intended to gain a better understanding of the safety profile of investigational zanamivir and of clinical outcomes in the large number of patients treated outside of a clinical trial setting.

Conditions

  • Infections, Respiratory Tract

Interventions

OTHER

retrospective chart review

retrospective chart review

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-01-31
Completion
2012-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01353768 on ClinicalTrials.gov